In April, Arterium Corporation presented two new original products for the treatment of upper respiratory tract infections (URTI) – Narivent and Rinogermina, both nasal sprays.

Galychpharm undergone a routine GMP compliance inspection by the State Inspectorate for Quality Control of Medicines . The inspection was initiated by Galychpharm to extend the validity of its GMP certificate.

Arterium Corporation has presented a brochure under the title What You Should Know About Atrial Fibrillation. The publication is a part of What You Should Know – the company’s educational initiative launched to inform patients in a professional and popular manner about cardiac diseases, their causes, and prevention measures.

On the occasion of the World Antibiotics Awareness Week, Arterium Corporation has launched a number of social projects, using videos, articles, and studies alike to raise awareness and help make the antibiotics use safer.

Arterium Corporation has made its dietary supplement Hepametion available in the form of tablets. The product is a follow-up to Hepametion solution for injection.